ES2004099A6 - Procedimiento de preparacion de polipeptidos biologicamente activos - Google Patents

Procedimiento de preparacion de polipeptidos biologicamente activos

Info

Publication number
ES2004099A6
ES2004099A6 ES8700432A ES8700432A ES2004099A6 ES 2004099 A6 ES2004099 A6 ES 2004099A6 ES 8700432 A ES8700432 A ES 8700432A ES 8700432 A ES8700432 A ES 8700432A ES 2004099 A6 ES2004099 A6 ES 2004099A6
Authority
ES
Spain
Prior art keywords
procedure
preparation
biologically active
polypeptides
active polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700432A
Other languages
English (en)
Inventor
Gerard Redziniak
Alain Meybeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Moet Hennessy Recherche
Original Assignee
Moet Hennessy Recherche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9332503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2004099(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Moet Hennessy Recherche filed Critical Moet Hennessy Recherche
Publication of ES2004099A6 publication Critical patent/ES2004099A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE POLIPEPTIDOS BIOLOGICAMENTE ACTIVOS PARA HIDROLISIS DE SUSTANCIAS NATURALES EN MEDIOS ACUOSOS, CARACTERIZADO PORQUE COMPRENDE LAS ETAPAS SIGUIENTES: A) SE PREPARA UN HOMOGENEIZADO ACUOSO DE SUSTANCIAS NATURALES, B) SE REALIZA LA HIDROLISIS ENZIMATICA CON UN AGENTE DE HIDROLISIS QUE COMPRENDE LA ALFA©QUIMOTRIPSINA, C) SE SEPARA DEL HIDROLIZADO UNA FRACCION QUE COMPRENDE LOS POLIPEPTIDOS DE PESO MOLECULAR DETERMINADO Y SE RECOGE ESTA FRACCION. LOS POLIPEPTIDOS OBTENIDOS SON UTILES POR SUS ACCIONES SOBRE LAS CELULAS IN VIVO Y/O IN VITRO.
ES8700432A 1986-02-25 1987-02-20 Procedimiento de preparacion de polipeptidos biologicamente activos Expired ES2004099A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8602576A FR2594847B1 (fr) 1986-02-25 1986-02-25 Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant

Publications (1)

Publication Number Publication Date
ES2004099A6 true ES2004099A6 (es) 1988-12-01

Family

ID=9332503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700432A Expired ES2004099A6 (es) 1986-02-25 1987-02-20 Procedimiento de preparacion de polipeptidos biologicamente activos

Country Status (5)

Country Link
EP (1) EP0237398B1 (es)
JP (1) JPS62236499A (es)
DE (2) DE3780047T2 (es)
ES (1) ES2004099A6 (es)
FR (1) FR2594847B1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
JPH0311007A (ja) * 1989-06-06 1991-01-18 Mikimoto Seiyaku Kk 化粧品原料の製造方法
FR2651679B1 (fr) * 1989-09-08 1994-06-03 Imedex Application d'hydrolysats de globines pour la stimulation cellulaire et produits pharmaceutiques et cosmetiques obtenus.
TW233264B (es) * 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
FR2707647A1 (fr) * 1993-07-16 1995-01-20 Rocher Yves Biolog Vegetale Dérivés d'alpha-hydroxy acides et composition cosmétique ou pharmaceutique les contenant.
FR2758458B1 (fr) 1997-01-21 2000-01-07 Jean Noel Thorel Produits cosmetiques ou dermo-pharmaceutiques respectant l'ecologie cutanee
DE59711975D1 (de) * 1997-05-26 2004-11-04 Lore Maria Klett-Loch Synthetische, statistische thymuspeptid-kombination und deren verwendung als immunologisch und/oder endokrinologisch wirkendes praparat
US6458761B2 (en) 1999-11-24 2002-10-01 Lore Maria Klett-Loch Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect
FR2927254B1 (fr) * 2008-02-12 2010-03-26 Lesaffre & Cie Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
FR2954697B1 (fr) * 2009-12-24 2016-11-04 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un extrait de caroube en tant qu'agent actif activateur de l'expression des aquaporines
DE102013017203A1 (de) * 2013-10-16 2015-04-16 Isa Atay Thymustherapie
MX2022006590A (es) * 2019-12-02 2022-09-19 Avant Meats Company Ltd Metodos de produccion de carne por cultivo celular in vitro.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
JPS50123889A (es) * 1974-03-06 1975-09-29
DE2537618B2 (de) * 1975-08-23 1980-05-08 Fa. Carl Freudenberg, 6940 Weinheim Zusatzstoff für Nahrungsmittel
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
JPS57144983A (en) * 1981-02-27 1982-09-07 Otsuka Pharmaceut Factory Inc Preparation of physiologically active substance
JPS591463A (ja) * 1982-06-28 1984-01-06 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
DE3230151A1 (de) * 1982-08-13 1984-02-16 Hoechst Ag, 6230 Frankfurt Neues polypeptid mit wirkung auf das immunsystem, verfahren zu seiner isolierung und reinigung, seine verwendung, dieses enthaltende mittel sowie seine spaltprodukte, deren verwendung und diese enthaltende mittel
JPS604200A (ja) * 1983-06-20 1985-01-10 Taisho Pharmaceut Co Ltd プレグナン系ステロイド化合物
JPS60226834A (ja) * 1984-04-26 1985-11-12 Nippon Zeon Co Ltd イソプレンの製造法
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
FR2565984B1 (fr) * 1984-06-19 1986-08-29 Rhone Poulenc Sante Nouvelles substances biologiquement actives, leur procede de preparation a partir du fibrinogene bovin et les compositions qui les contiennent
US4693856A (en) * 1985-04-22 1987-09-15 The Dow Chemical Company Method and apparatus for the preparation of foamed thermoplastic articles

Also Published As

Publication number Publication date
FR2594847A1 (fr) 1987-08-28
DE3780047T2 (de) 1992-12-24
DE237398T1 (de) 1988-06-09
JPS62236499A (ja) 1987-10-16
EP0237398A1 (fr) 1987-09-16
FR2594847B1 (fr) 1989-06-02
DE3780047D1 (de) 1992-08-06
EP0237398B1 (fr) 1992-07-01

Similar Documents

Publication Publication Date Title
ES2004843T3 (es) Procedimiento de obtencion de un equivalente de piel y equivalente de piel correspondiente.
ES8600389A1 (es) Procedimiento para la produccion de una linea celular humana independiente de suero
ATE86128T1 (de) Gewebeimplantat.
ES2099211T3 (es) Conjugados citomoduladores de miembros de parejas de union especifica.
CO5580844A2 (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas
MX9302917A (es) Derivados de proteinas c humanas, procedimiento para su preparacion y formulacion famaceutica que los contiene.
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
FR2559780B1 (fr) Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES8705036A1 (es) Procedimiento para preparar una vacuna que comprende un polipeptido fijado a una membrana
ES2030012T3 (es) Pared de vaso artificial.
BR9910251A (pt) Estimulação hematopoiética
ES2091938T3 (es) Canula.
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
ES2052872T3 (es) Procedimiento de inactivacion de virus.
JPS57188513A (en) Cysteine release system
ES2000871A6 (es) Un procedimiento para producir un copolimero de bloques selectivamente hidrogenado y fuoncionalizado
ES2059436T3 (es) Proteina de la membrana exterior f de pseudomonas aeruginosa.
ES2151517T3 (es) Efectos de filamentos de actina sobre la estructura y lisis de coagulos de fibrina.
DE3381918D1 (de) Biologisch-kuenstlicher pankreas unter verwendung von ultrafiltration.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
ES2000435T3 (es) Procedimiento de purificacion de antigenos proteinicos de bacterias que pertenecen al genero bordetella, en vista a la obtencion de una vacuna acelular.
ES2118720T3 (es) Produccion y utilizacion de agentes antihelminticos e inmunogenos protectores.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20011110